Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SOMAGEN HEALTHCARE INC

NPI: 1316225147 · CHULA VISTA, CA 91910 · Primary Care Clinic/Center · NPI assigned 07/27/2011

$1.41M
Total Medicaid Paid
35,636
Total Claims
33,972
Beneficiaries
16
Codes Billed
2018-01
First Month
2024-07
Last Month

Provider Details

Authorized OfficialLAREAUX, DANIEL (MEDICAL DIRECTOR)
Parent OrganizationSOMAGEN HEALTHCARE INC
NPI Enumeration Date07/27/2011

Related Entities

Other providers sharing the same authorized official: LAREAUX, DANIEL

ProviderCityStateTotal Paid
SOMAGEN HEALTHCARE INC SANTEE CA $2.62M
SOMAGEN HEALTHCARE INC SAN DIEGO CA $1.89M
SOMAGEN HEALTHCARE INC SAN DIEGO CA $947K
SOMAGEN HEALTHCARE INC SAN DIEGO CA $864K
SOMAGEN HEALTHCARE INC GRANADA HILLS CA $417K
SOMAGEN HEALTHCARE INC SAN DIEGO CA $99K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 4,194 $168K
2019 5,387 $197K
2020 6,048 $212K
2021 6,509 $260K
2022 5,795 $240K
2023 4,838 $192K
2024 2,865 $145K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 7,071 6,795 $581K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 6,137 6,109 $566K
S9088 Services provided in an urgent care center (list in addition to code for service) 9,992 9,518 $77K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 754 749 $71K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 539 521 $49K
99215 Prolong outpt/office vis 559 551 $40K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,059 1,995 $10K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,244 623 $6K
99000 2,097 2,060 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 745 739 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 170 166 $2K
99051 919 887 $2K
81003 1,593 1,549 $2K
81025 670 656 $1K
99072 1,074 1,041 $572.97
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 13 13 $37.31